Department of Pharmacy, KU & Danish Pharmaceutical Society (The Biopharmaceutical Section)

Overcoming the skin barrier

Wednesday 31st of May, 2023 at 14.30

The number of people suffering from skin disorders, such as atopic dermatitis, is continuously increasing, resulting in increased healthcare costs and significant decrease in the patient’s quality of life. However, despite much research within the area, overcoming the skin barrier is still highly challenging. Recently, novel promising delivery strategies has been developed, together with a more detailed understanding of the skin immune system.

This seminar brings together leading experts within dermatology, providing an overview of the skin barrier as seen from a clinical perspective, when developing cutaneous formulations, immunological aspects and finally a case study on non-invasive extraction of biomarkers from the skin.


14.30-14.35 Welcome and introduction
Stine Rønholt, LEO Foundation Center for Cutaneous Drug Delivery / Danish Pharmaceutical Society

14.35-15.00 A clinician’s perspective on challenges within treatment of atopic dermatitis
Anne-Sofie Halling-Sønderby, MD, PhD Fellow, Bispebjerg Hospital

15.00-15.45 Novel strategies to overcome the skin barrier
Samir Mitragotri, Professor, Wyss Institute at Harvard University

15:45-16.05 Break with refreshments

16.05-16.30 From diseased skin to robust and long-term homeostasis
Liv Eidsmo, Prof. & Executive Director, Skin Immunology Research Center, Uni. of Copenhagen

16.30-16.55 Bicontinuous cubic liquid crystals as potential matrices for noninvasive topical sampling of low molecular weight biomarkers
Johan Engblom, Professor & Dept. head, Dept. of Biomedical Science, Malmö University

16.55-17.00 Wrap up
Stine Rønholt & Gitte Pommergaard Pedersen, Danish Pharmaceutical Society


31. May – 14:30

31. May – 17:00


A3, School of Pharmaceutical Sciences
Universitetsparken 2, 2100 Copenhagen Ø

No entry fee, non-members are also welcome

Sign up

Fill in form to sign up for this event
Registration no later than May 20th